Literature DB >> 11278991

Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication.

Y Tokuyama1, H F Horn, K Kawamura, P Tarapore, K Fukasawa.   

Abstract

The kinase activity of cyclin-dependent kinase 2 (CDK2)-cyclin E is required for centrosomes to initiate duplication. We have recently found that nucleophosmin (NPM/B23), a phosphoprotein primarily found in nucleolus, associates with unduplicated centrosomes and is a direct substrate of CDK2-cyclin E in centrosome duplication. Upon phosphorylation by CDK2-cyclin E, NPM/B23 dissociates from centrosomes, which is a prerequisite step for centrosomes to initiate duplication. Here, we identified that threonine 199 (Thr(199)) of NPM/B23 is the major phosphorylation target site of CDK2-cyclin E in vitro, and the same site is phosphorylated in vivo. NPM/T199A, a nonphosphorylatable NPM/B23 substitution mutant (Thr(199) --> Ala) acts as dominant negative when expressed in cells, resulting in specific inhibition of centrosome duplication. As expected, NPM/T199A remains associated with the centrosomes. These observations provide direct evidence that the CDK2-cyclin E-mediated phosphorylation on Thr(199) determines association and dissociation of NPM/B23 to the centrosomes, which is a critical control for the centrosome to initiate duplication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278991     DOI: 10.1074/jbc.M100014200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

1.  Inactivation of E2F3 results in centrosome amplification.

Authors:  Harold I Saavedra; Baidehi Maiti; Cynthia Timmers; Rachel Altura; Yukari Tokuyama; Kenji Fukasawa; Gustavo Leone
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

2.  The cyclin A centrosomal localization sequence recruits MCM5 and Orc1 to regulate centrosome reduplication.

Authors:  Rebecca L Ferguson; Gaetan Pascreau; James L Maller
Journal:  J Cell Sci       Date:  2010-07-27       Impact factor: 5.285

3.  Compartmentation of the nucleolar processing proteins in the granular component is a CK2-driven process.

Authors:  Emilie Louvet; Henriette Roberte Junéra; Isabelle Berthuy; Danièle Hernandez-Verdun
Journal:  Mol Biol Cell       Date:  2006-03-15       Impact factor: 4.138

Review 4.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

5.  Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.

Authors:  S N Brady; L B Maggi; C L Winkeler; E A Toso; A S Gwinn; C L Pelletier; J D Weber
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

6.  B23 is a downstream target of polyamine-modulated CK2.

Authors:  Kathryn Lawson; Laura Larentowicz; Lisa Laury-Kleintop; Susan K Gilmour
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

7.  ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.

Authors:  Suzanne N Brady; Yue Yu; Leonard B Maggi; Jason D Weber
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints.

Authors:  Stephan C Jahn; Patrick E Corsino; Bradley J Davis; Mary E Law; Peter Nørgaard; Brian K Law
Journal:  J Cell Sci       Date:  2013-01-15       Impact factor: 5.285

9.  Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.

Authors:  Lisa K Pierson-Mullany; Carol A Lange
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Nucleophosmin sets a threshold for p53 response to UV radiation.

Authors:  Dony A Maiguel; Leslie Jones; Devulapalli Chakravarty; Chonglin Yang; France Carrier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.